SmithKline, Glaxo deal wins 2 votes

Article Abstract:

Shareholders of Glaxo Wellcome PLC and of SmithKline Beecham PLC voted approval of the $75 billion merger of the two drug companies, creating the world's second largest when it takes effect Sept. 25. New headquarters will be London. In the US headquarters will be Center City, PA, and North Carolina. The two do not have FDA approval as yet.

Strategy & planning

---

SmithKline grew faster than Glaxo

Article Abstract:

London, England-based Glaxo Wellcome PLC, which reported a 5% increase in sales for 1999, will merge with London, England-based SmithKline Beecham PLC. SmithKline, which had its U.S. headquarters is in Philadelphia, reported a 10% increase in sales for 1999.

Sales, profits & dividends

---

GlaxoSmithKline's birth may be delayed until 2001

Article Abstract:

The fourth self-imposed deadline for SmithKline Beecham PLC and Glaxo Wellcome PLC to complete their merger is fast approaching. The deadline for their planned $76 billion merger is the end of 2000.

Drugs & Pharmaceuticals, Pharmaceutical and Medicine Manufacturing, Drugs

Similar abstracts:

• Abstracts: Inquiry by FTC delays merger; SmithKline Beecham and Glaxo Wellcome planned to unite Spet. 25. SmithKline says profits rose 10%
• Abstracts: Competition leads hotels to beef up frequent-guest programs. Green light for ex-Trump executive
• Abstracts: Cell-phone firm faces an unwanted test at McVeigh's execution. Price questioned as Comcast sells cellular business
• Abstracts: Franklin Electronic Publishers warns of loss. Unisys backs state SciTech internships. Revenue down, but profit up at Unisys
• Abstracts: Its merger off, Reliance Group seeks a future. Pa. insurer's embattled chief resigns. Reliance Group reorganizing as CEO steps down

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.